HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
STRR
Star Equity Holdings, Inc.
There isn't enough reported data to score STRR yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
STRR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Strong |
STRR's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
STRR PE Valuation
STRR has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
STRR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
STRR has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over STRR on earnings, with more consistent year-over-year improvement.
STRR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.50 | — |
| Q3 2026 | -$2.43 | -$0.86 |
| Q2 2026 | -$2.54 | -$1.23 |
| Q1 2026 | -$2.27 | -$1.04 |
| Q4 2025 | -$1.85 | -$0.26 |
| Q3 2025 | -$1.57 | -$0.43 |
| Q2 2025 | -$1.31 | -$0.62 |
| Q1 2025 | -$1.23 | -$0.87 |
| Q4 2024 | -$1.59 | -327% |
STRR lost $2.43 per share over the past year, a bigger loss than the year before.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over STRR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
STRR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $53.9M | +12% |
| Q2 2026 | $54.9M | +55% |
| Q1 2026 | $50.1M | +57% |
| Q4 2025 | $56.8M | +69% |
| Q3 2025 | $48M | +30% |
| Q2 2025 | $35.5M | -0.5% |
| Q1 2025 | $31.9M | -6% |
| Q4 2024 | $33.6M | -1.1% |
STRR's revenue has grown year over year for five quarters in a row: $54M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -3.4% | +0.1 points |
| Q2 2026 | -2.5% | -1.9 points |
| Q1 2026 | -8% | -2.6 points |
| Q4 2025 | -0.2% | +0.2 points |
| Q3 2025 | -3.4% | -2.2 points |
| Q2 2025 | -0.6% | -0.1 points |
| Q1 2025 | -5.4% | +3.6 points |
| Q4 2024 | -0.4% | +3.4 points |
STRR has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over STRR on cash generation, producing positive trailing cash flow while its opponent burns cash.
STRR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60K | +$3.4M |
| Q2 2026 | -$3.2M | -3269% |
| Q1 2026 | -$2.7M | -$1.9M |
| Q4 2025 | -$4.9M | -342% |
| Q3 2025 | -$3.4M | -368% |
| Q2 2025 | $102K | +$4.4M |
| Q1 2025 | -$808K | +$986K |
| Q4 2024 | $2M | -39% |
STRR's free cash flow was −$11M over the past year, against −$2M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over STRR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
STRR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -3K shares |
| 1 year | +13% | +438K shares |
| 3 years | +18% | +560K shares |
| 5 years | +22% | +679K shares |
| Available history | +18% | +570K shares |
STRR has 4M diluted shares, up 13% from a year ago, despite $1M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $306,000 |
| Q2 2026 | $157,000 |
| Q1 2026 | $712,000 |
| Q4 2025 | $66,000 |
| Q3 2025 | $2.6M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
STRR spent $1M buying back its own shares over the past year, down 52% from the year before.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
STRR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -7.9x | Net Cash |
| Q3 2023 | -4.6x | Net Cash |
| Q2 2023 | -4.9x | Net Cash |
| Q1 2023 | -2.9x | Net Cash |
| Q4 2022 | -2.4x | Net Cash |
| Q3 2022 | -1.7x | Net Cash |
| Q2 2022 | -1.9x | Net Cash |
| Q1 2022 | -2.0x | Net Cash |
STRR has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
STRR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.3 | Neutral |
| Stochastic | 26.2 | Neutral |
STRR's weekly RSI is 48 (neutral) and its Stochastic is 26 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
STRR PE vs Healthcare Sector
| Metric | STRR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
STRR has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
STRR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.84 | 1.6% above |
| 20 week MA | $10.3 | 2.9% below |
| 50 week MA | $10.3 | 3.1% below |
| 100 week MA | $10.4 | 3.6% below |
| 200 week MA | $14.2 | 30% below |
STRR has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
STRR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.5 | $10.7 | -14% |
| 2021 | $10.7 | $27.4 | +155% |
| 2022 | $27.4 | $23.5 | -14% |
| 2023 | $23.5 | $15.5 | -34% |
| 2024 | $15.5 | $13.4 | -14% |
| 2025 | $13.4 | $10.9 | -18% |
| 2026 YTD | $10.9 | $10.0 | -8.4% |
STRR has the edge over HIMS on returns for 2026, with the stronger performance.